A Bioprocess Design for Microbial Production of Taxol

Project Summary

Paclitaxel (Taxol) is a small molecule drug belonging to the taxane family. It is one of the most commonly used chemotherapeutics, used for treatment of many cancers, as a monotherapy or in combination with other drugs to treat breast, lung and ovarian cancer as well as Kaposi’s sarcoma. Taxol is on the World Health Organization’s (WHO) List of Essential Medicines, a list that includes most the important medications for basic health. The worldwide demand for paclitaxel is exceeding the current supply. 

Themes and Categories
Health
Health Systems Operations
Year
2015

In addition the current cost of paclitaxel limits use in many parts of the developing world. Lower cost sources of paclitaxel can have an immediate impact to human health worldwide. Currently taxol is approved in the U.S. as first line of treatment for breast, ovarian and non-small cell lung cancer. The annual new cases of these cancers are ~ 540,000 in the United States.

Project Team

  • Banskota, S.
  • Ciesla T.J.
  • Moreb, E.

BME 590-02 Fall 2015 

Project Details

Market size: U.S. market : 1,100 kg per year

Process design included:

  • Genetically engineered E. coli Strain
  • Heterologous Taxol production pathway
  • Engineered host strain
  • GMP fermentation process
  • 5 step downstream recovery process 

Results

Our conceptual design results in cost competitive production 

  • $0.43/mg - including a 25% return
  • ~$ 5M in capital investment
  • Current pricing is ~ $0.50/mg 

Download the project poster for more details (PDF).

Related People

Related Projects

Big Data for Reproductive Health (Year 2)

A team of students led by faculty and researchers from the School of Medicine, the Center for Global Reproductive Health at the Duke Global Health Institute, and the Duke Evidence Lab will collaborate on the user interface for a tool developed to help advocates and policymakers target family planning resources to key populations in low resource populations. Team members will traverse the app development lifecycle while contributing to a tool that can improve global reproductive health.

Faculty Lead: Megan Huchko

Project Manager: Amy Finnegan

Urodynamic Data and Machine Learning

A team of students led by Drs. Aquino (Engineering) and Routh (Urologic Surgery) will develop objective algorithms in order to guide data interpretation from a urology test, known as urodynamics, which is used in children with spina bifida in order to define a patient’s risk of debilitating bladder and kidney complications.  Urodynamics involves dynamic pressure monitoring as the bladder is filled with fluid.  This project is part of a 21-institution collaboration coordinated and funded by the U.S. Centers for Disease Control and Prevention (CDC), with the long-term goal of defining optimal management strategies for children with spina bifida. The short-term goal of this Data+ application is to define initial features of urodynamics that can be applied to increasingly complex future algorithms in order to guide clinical interpretations that determine whether, for example, children need reconstructive surgery in order to avoid complications of their disease.

Faculty Leads: Wilkins Aquino, Jonathan Routh

Optimizing Risk Assessment for Duke University Student Athlete Injury Prevention

A team of students led by researchers from the Michael W. Krzyzewski Human Performance Laboratory (K-Lab) will develop an analytic and report generating web-based application to help the K-Lab reduce musculoskeletal injuries in student-athletes at Duke University. This tool will produce actionable, student-athlete-specific reports that incorporate the analysis of previous injury history and current capabilities (K-Lab assessments) in order to identify injury risk and develop individualized recommendations for injury prevention. Students will develop analytic tools and scoring criteria to assess injury risk through profiling of data based on minimally clinically important differences, injury profiles, peer group analysis, and injury risk scoring strategies based on a comprehensive set of performance metrics. Injury risk identification will be furthered enhanced by clustering data analysis around joint or tissue specific injury risk, previous injury history, and athlete capabilities (strength, flexibility, and postural stability). The final deliverable will enhance injury prevention strategies for student-athletes and other populations by bridging the analytic gap between injury risk screening and actionable injury prevention strategies.

Faculty Lead: Dr. Tim Sell

Project Manager: Brinnae Bent